Literature DB >> 29611513

Adjuvant therapy in colon cancer: less is more.

David H Ilson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29611513     DOI： 10.1016/S1470-2045(18)30127-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade.

Authors:  Aaron C Tan; J Matt McCrary; Susanna B Park; Terry Trinh; David Goldstein
Journal:  Support Care Cancer       Date:  2019-04-10       Impact factor: 3.603

Review 2.  The Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer: the European Perspective.

Authors:  Giacomo Bregni; Sara Elena Rebuzzi; Alberto Sobrero
Journal:  Curr Treat Options Oncol       Date:  2019-01-26

3.  Identification of critical genes to predict recurrence and death in colon cancer: integrating gene expression and bioinformatics analysis.

Authors:  Xuan Long; Zhigang Deng; Guoqiang Li; Ziwei Wang
Journal:  Cancer Cell Int       Date:  2018-09-17       Impact factor: 5.722

4.  B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells.

Authors:  Huimin Lu; Tongguo Shi; Mingyuan Wang; Xiaomi Li; Yanzheng Gu; Xueguang Zhang; Guangbo Zhang; Weichang Chen
Journal:  Oncoimmunology       Date:  2020-04-14       Impact factor: 8.110

Review 5.  Recent Advances in Polymer Nanomaterials for Drug Delivery of Adjuvants in Colorectal Cancer Treatment: A Scientific-Technological Analysis and Review.

Authors:  Marlon Osorio; Estefanía Martinez; Tonny Naranjo; Cristina Castro
Journal:  Molecules       Date:  2020-05-12       Impact factor: 4.411

6.  Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials.

Authors:  Xia-Hong You; Yu-Huan Jiang; Zhou Fang; Fan Sun; Yao Li; Wei Wang; Zi-Jin Xia; Xiao-Zhong Wang; Hou-Qun Ying
Journal:  ESMO Open       Date:  2020-03

7.  Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation.

Authors:  Ming Hong; Jinke Li; Siying Li; Mohammed M Almutairi
Journal:  Cells       Date:  2019-11-19       Impact factor: 6.600
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.